Back to today’s briefing

Story perspectives

States Revise Cannabis Regulations Amid Controversies and Criticism

8/15/2025

35 8

Summary

Story summary

Oklahoma, Louisiana, Ohio, New Jersey, Michigan, and Minnesota are revising medical cannabis regulations on compliance, product naming, and packaging.
New Jersey is examining THCA and mold testing results in marijuana products.
New York's ex-marijuana regulator criticized Governor Hochul over a zoning decision affecting cannabis businesses, which she contests.

History

Historical Context

California's legalization of recreational cannabis in November 2016 marked a significant shift in U.S. drug policy, following the earlier passage of Proposition 215 in 1996 for medical use. By 2018, cannabis sales in California reached $1 billion, prompting other states like Oklahoma and New Jersey to revise their regulations, reflecting a broader trend towards stricter compliance and safety standards in the cannabis industry.

1 of 2

Story summary

Oklahoma, Louisiana, Ohio, New Jersey, Michigan, and Minnesota are revising medical cannabis regulations on compliance, product naming, and packaging.
New Jersey is examining THCA and mold testing results in marijuana products.
New York's ex-marijuana regulator criticized Governor Hochul over a zoning decision affecting cannabis businesses, which she contests.

1 / 2